H.R.2369 - VALID Act of 2023
FDA Proposed rule on LDTs
No bill #: Precision Medicine Access for Kids Today Act
S.2140: Patent Eligibility Restoration Act
Duration: February 1, 2019
to
present
General Issues: Medical/Disease Research/Clinical Labs , Medicare/Medicaid , Copyright/Patent/Trademark , Budget/Appropriations , Health Issues , Consumer Issues/Safety/Protection
Spending: about $1,500,500 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2019: U.S. Senate, House of Representatives, Office of Science & Technology Policy (OSTP), Food & Drug Administration (FDA), Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Agency for Healthcare Research & Quality (AHRQ), Natl Institutes of Health (NIH), Veterans Affairs - Dept of (VA), Centers For Disease Control & Prevention (CDC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Jennifer Leib
Fellow, Senate Committee on Health, Education, Labor, and Pensions
Fellow, Senate Committee on Health, Education, Pensions, and Labor
Fellow, Senate Committee on Health, Education, Labor and Pensions
Fellow, Senate Committee on Health Education Labor and Pensions
Legislative Fellow, Senate Health, Education, Labor and Pensions Committee
Megan Anderson Brooks
n/a
Jay Qiu
n/a
Lindsey Trischler
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, iPolicy Solutions lobbied for Invitae Inc. , earning $40,000. The report was filed on April 15.
Original Filing: 301549462.xml
Lobbying Issues
H.R.2369 - VALID Act of 2023
FDA Proposed rule on LDTs
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill #: Precision Medicine Access for Kids Today Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.2140: Patent Eligibility Restoration Act
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2023
In Q4, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on Feb. 2.
Original Filing: 301542776.xml
Lobbying Issues
H.R.2369 - VALID Act of 2023
FDA Proposed rule on LDTs
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill #: Precision Medicine Access for Kids Today Act
H.R.1526: Reducing Hereditary Cancer Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.2140: Patent Eligibility Restoration Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
No bill #: FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill
H.R.4366/S.2127: FY2024 Military Construction, Veterans Affairs, and Related Agencies Appropriations bill
H.R.2670: National Defense Authorization Act for FY24
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on Oct. 16, 2023.
Original Filing: 301501417.xml
Lobbying Issues
H.R.2369 - VALID Act of 2023
FDA RFI: Increasing Patient Access to At-Home Use Medical
Technologies
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill #: Precision Medicine Access for Kids Today Act
H.R.1526: Reducing Hereditary Cancer Act
H.R. 3876/S. 2323: Access to Genetic Counseling Services Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.2140: Patent Eligibility Restoration Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
No bill #: Right Drug Dose Now Act
No bill #: Pharmacogenomics Education and Research Act
FTC-2023-0037 Health Breach Notification Rule, Project No. P205405
Agencies Lobbied
U.S. House of Representatives U.S. Senate Federal Trade Commission (FTC)
Lobbying Issues
No bill #: FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill
H.R.4366/S.2127: FY2024 Military Construction, Veterans Affairs, and Related Agencies Appropriations bill
H.R.2670: National Defense Authorization Act for FY24
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on July 10, 2023.
Original Filing: 301474065.xml
Lobbying Issues
H.R.2369 - VALID Act of 2023
FDA Guidance, Docket No. FDA-2022-D-2983 for Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products
FDA public meeting, FDA-2018-N-4002 Electronic Submission of Adverse Event Reports to FAERS Using ICH E2B(R3) Standards
FDA guidance, Docket No. FDA-2023-D-0110: Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill #: Precision Medicine Access for Kids Today Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.2140: Patent Eligibility Restoration Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
No bill #: Right Drug Dose Now Act
H.R.4189/S.2016: CONNECT for Health Act
No bill #: Pharmacogenomics Education and Research Act
RIN 0945-AA20, HIPAA Privacy Rule to Support Reproductive Health Care Privacy
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
No bill #: FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill
H.R.4366/S.2127: FY2024 Military Construction, Veterans Affairs, and Related Agencies Appropriations bill
H.R.2670: National Defense Authorization Act for FY24
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on April 17, 2023.
Original Filing: 301452536.xml
Lobbying Issues
H.R.2369 - VALID Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill #: Precision Medicine Access for Kids Today Act
H.R.1789/S.642 Finn Sawyer Access to Cancer Testing Act
H.R.1526/S.765 Reducing Hereditary Cancer Act
CMS-9898-NC, Request for Information; Essential Health Benefits.
87FR76044; Healthcare System Level Strategies to Address Racial/Ethnic and Related Disparities in Health and Healthcare
Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Advancing Interoperability and Improving Prior Authorization Processes for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Childrens Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges, Merit-Based Incentive Payment System (MIPS) Eligible Clinicians, and Eligible Hospitals and Critical Access Hospitals in the Medicare Promoting Interoperability Program (CMS-0057-P)
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Agency for Healthcare Research & Quality (AHRQ)
Lobbying Issues
No bill #: Patent Eligibility Restoration Act
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
No bill #: Right Drug Dose Now Act
No bill#: CONNECT for Health Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
No bill #: FY2024 Labor, Health and Human Services, Education and Related Agencies Appropriations bill
No bill number: FY2024 Military Construction, Veterans Affairs, and Related Agencies Appropriations bill
No bill #: Military Construction, Veterans Affairs, and Related Agencies Appropriations bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on Jan. 3, 2023.
Original Filing: 301424721.xml
Lobbying Issues
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.5989 - Precision Medicine Answers for Kids Today Act
Enhancing Oncology Model
Section 112 of title I of Division BB of the Consolidated Appropriations Act 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS)
Lobbying Issues
S.4734 Patent Eligibility Restoration Act
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R. 6000 Cures 2.0 Act
H.R.6875 - Right Drug Dose Now Act
Diversity in clinical trials
Health equity
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Office of Science & Technology Policy (OSTP)
Lobbying Issues
H.R.8152 American Data Privacy and Protection Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
Lobbying Issues
H.R.2617 - Consolidated Appropriations Act, 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on Oct. 17, 2022.
Original Filing: 301406017.xml
Lobbying Issues
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
S.4348 - FDASLA Act of 2022
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.5989 - Precision Medicine Answers for Kids Today Act
Enhancing Oncology Model
Information blocking
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) Natl Institutes of Health (NIH)
Lobbying Issues
S.4734 Patent Eligibility Restoration Act
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R. 6000 Cures 2.0 Act
H.R.6875 - Right Drug Dose Now Act
Cancer Moonshot
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS)
Lobbying Issues
H.R.8152 American Data Privacy and Protection Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
2nd Quarter, 2022
iPolicy Solutions amended a lobbying report for representation of Invitae Inc. in Q22022 on July 19, 2022.
Original Filing: 301384967.xml
Lobbying Issues
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
S.4348 - FDASLA Act of 2022
FDA Draft Guidance on ctDNA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.5989 - Precision Medicine Answers for Kids Today Act
Molecular Pathology Coding and Reimbursement
Oncology Care Model
Medicare Promoting Interoperability Program
Information blocking
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Science & Technology Policy (OSTP) Health & Human Services - Dept of (HHS)
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R. 6000 Cures 2.0 Act
H.R.6875 - Right Drug Dose Now Act
S.3799 - PREVENT Pandemics Act
Cancer Moonshot
Agencies Lobbied
U.S. House of Representatives U.S. Senate Office of Science & Technology Policy (OSTP) Health & Human Services - Dept of (HHS)
Lobbying Issues
H.R.8152 American Data Privacy and Protection Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
2nd Quarter, 2022
In Q2, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on July 19, 2022.
Original Filing: 301384947.xml
Lobbying Issues
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
S.4348 - FDASLA Act of 2022
FDA Draft Guidance on ctDNA
Agencies Lobbied
U.S. Senate U.S. House of Representatives Food & Drug Administration (FDA)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.5989 - Precision Medicine Answers for Kids Today Act
Molecular Pathology Coding and Reimbursement
Oncology Care Model
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Science & Technology Policy (OSTP)
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R. 6000 Cures 2.0 Act
H.R.6875 - Right Drug Dose Now Act
S.3799 - PREVENT Pandemics Act
Cancer Moonshot
Agencies Lobbied
U.S. House of Representatives U.S. Senate Office of Science & Technology Policy (OSTP) Health & Human Services - Dept of (HHS)
Lobbying Issues
H.R.8152 American Data Privacy and Protection Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Consumer Issues/Safety/Protection
1st Quarter, 2022
In Q1, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on April 20, 2022.
Original Filing: 301365728.xml
Lobbying Issues
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.5989 - Precision Medicine Answers for Kids Today Act
H.R. 2144, Access to Genetic Counselor Services Act
H.R. 2903 CONNECT for Health Act
H.R. 708, TREAT Act
H.R.6202 - Telehealth Extension Act of 2021
Molecular Pathology Coding and Reimbursement
Oncology Care Model
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Office of Science & Technology Policy (OSTP)
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R. 6000 Cures 2.0 Act
H.R.6875 - Right Drug Dose Now Act
S.3799 - PREVENT Pandemics Act
Cancer Moonshot
Agencies Lobbied
U.S. House of Representatives U.S. Senate Office of Science & Technology Policy (OSTP)
4th Quarter, 2021
In Q4, iPolicy Solutions lobbied for Invitae Inc. , earning $90,000. The report was filed on Jan. 19, 2022.
Original Filing: 301328697.xml
Lobbying Issues
No bill number, The Right Act
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.5989 - Precision Medicine Answers for Kids Today Act
H.R. 2144, Access to Genetic Counselor Services Act
H.R. 2903 CONNECT for Health Act
H.R. 708, TREAT Act
H.R.6202 - Telehealth Extension Act of 2021
Molecular Pathology Coding and Reimbursement
Oncology Care Model
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2021
In Q3, iPolicy Solutions lobbied for Invitae Inc. , earning $80,000. The report was filed on Oct. 20, 2021.
Original Filing: 301308157.xml
Lobbying Issues
No bill number, The Right Act
HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill number, Advancing Access to Precision Medicine Act
H.R. 2144, Access to Genetic Counselor Services Act
H.R. 2903 CONNECT for Health Act
H.R. 708, TREAT Act
Molecular Pathology Coding and Reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Office of Science & Technology Policy (OSTP)
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Agencies Lobbied
U.S. Senate Office of Science & Technology Policy (OSTP)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
H.R.4355 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Social determinants of health
No bill number, Cures 2.0
Agencies Lobbied
U.S. House of Representatives U.S. House of Representatives
2nd Quarter, 2021
In Q2, iPolicy Solutions lobbied for Invitae Inc. , earning $75,000. The report was filed on July 16, 2021.
Original Filing: 301277472.xml
Lobbying Issues
Pharmacogenomic testing
CDC Advanced Molecular Detection Program
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill number, Advancing Access to Precision Medicine Act
H.R. 2144, Access to Genetic Counselor Services Act
H.R. 2903 CONNECT for Health Act
H.R. 708, TREAT Act
HR 1439 Expanded Genetic Screening Act
S.1362/HR2759 Pharmacy and Medically Underserved Areas Enhancement Act
Molecular Pathology Coding and Reimbursement
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
S1685 Preventive Health Savings Act
1st Quarter, 2021
In Q1, iPolicy Solutions lobbied for Invitae Inc. , earning $75,000. The report was filed on April 15, 2021.
Original Filing: 301253737.xml
Lobbying Issues
Emergency Use Authorization for COVID-19 Diagnostics
S.236 - Tracking COVID-19 Variants Act
CDC Advanced Molecular Detection Program
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
No bill number, Advancing Access to Precision Medicine Act
H.R. 2144, Access to Genetic Counselor Services Act
No bill number, CONNECT for Health Act
H.R. 708, TREAT Act
Scope of practice for non-physician providers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Veterans Affairs - Dept of (VA)
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2020
In Q4, iPolicy Solutions lobbied for Invitae Inc. , earning $65,000. The report was filed on Jan. 19, 2021.
Original Filing: 301234376.xml
Lobbying Issues
H.R.6102/S.3404, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.4393 - Advancing Access to Precision Medicine Act
H.R.3235 - Access to Genetic Counselor Services Act of 2019
S. 2741/H.R. 4932 CONNECT for Health Act
Scope of practice for non-physician providers
Coding practices for molecular diagnostics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020/ Senate: No bill number
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Electronic medical record interoperability
No bill number, 21st Century Cures 2.0 Act
Agencies Lobbied
Health & Human Services - Dept of (HHS) U.S. Senate U.S. House of Representatives
Lobbying Issues
U.S. Patent Act Sec. 101 reform
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2020
In Q3, iPolicy Solutions lobbied for Invitae Inc. , earning $60,000. The report was filed on Oct. 20, 2020.
Original Filing: 301217861.xml
Lobbying Issues
H.R.6102/S.3404, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.4393 - Advancing Access to Precision Medicine Act
H.R.3235 - Access to Genetic Counselor Services Act of 2019
S. 2741/H.R. 4932 CONNECT for Health Act
Scope of practice for non-physician providers
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS) Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
H.R.2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020/ Senate: No bill number
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Electronic medical record interoperability
Health data privacy
Agencies Lobbied
Health & Human Services - Dept of (HHS) U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, iPolicy Solutions lobbied for Invitae Inc. , earning $60,000. The report was filed on July 20, 2020.
Original Filing: 301194810.xml
Lobbying Issues
H.R.6102/S.3404, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.4393 - Advancing Access to Precision Medicine Act
H.R.3235 - Access to Genetic Counselor Services Act of 2019
S. 2741/H.R. 4932 CONNECT for Health Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.2740 Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020/ Senate: No bill number
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Electronic medical record interoperability
Agencies Lobbied
Health & Human Services - Dept of (HHS)
1st Quarter, 2020
In Q1, iPolicy Solutions lobbied for Invitae Inc. , earning $60,000. The report was filed on April 17, 2020.
Original Filing: 301170076.xml
Lobbying Issues
H.R.6102/S.3404, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R.4393 - Advancing Access to Precision Medicine Act
H.R.3235 - Access to Genetic Counselor Services Act of 2019
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
No bill #, Labor, HHS, Education and Related Agencies Appropriations FY21
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, iPolicy Solutions lobbied for Invitae Inc. , earning $60,000. The report was filed on Jan. 15, 2020.
Original Filing: 301106616.xml
Lobbying Issues
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare coverage of next generation sequencing based tests for cancer
H.R.4393 - Advancing Access to Precision Medicine Act
H.R.3235 - Access to Genetic Counselor Services Act of 2019
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
No bill #, Labor, HHS, Education and Related Agencies Appropriations FY20
No bill #, Labor, HHS, Education and Related Agencies Appropriations FY21
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
No bill #, reform Sec. 101 of the Patent Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2019
In Q3, iPolicy Solutions lobbied for Invitae Inc. , earning $58,000. The report was filed on Oct. 11, 2019.
Original Filing: 301064822.xml
Lobbying Issues
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare coverage of next generation sequencing based tests for cancer
H.R.4393 - Advancing Access to Precision Medicine Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
No bill #, Labor, HHS, Education and Related Agencies Appropriations FY20
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
No bill #, reform Sec. 101 of the Patent Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2019
In Q2, iPolicy Solutions lobbied for Invitae Inc. , earning $37,500. The report was filed on July 21, 2019.
Original Filing: 301053468.xml
Lobbying Issues
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare coverage of next generation sequencing based tests for cancer
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
No bill #, Labor, HHS, Education and Related Agencies Appropriations FY20
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
No bill #, reform Sec. 101 of the Patent Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2019
In Q1, iPolicy Solutions lobbied for Invitae Inc. , earning $20,000. The report was filed on April 8, 2019.
Original Filing: 301023321.xml
Lobbying Issues
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Medicare coverage of next generation sequencing based tests for cancer
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
No bill #, Labor, HHS, Education and Related Agencies Appropriations FY20
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
iPolicy Solutions filed a lobbying registration on March 4, 2019 to represent Invitae Inc., effective Feb. 1, 2019.
Original Filing: 301021090.xml
Issue(s) they said they’d lobby about: Coverage and reimbursement of molecular diagnostics
No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate